Scholar
Google Scholar Results
DESKTOP TABLET MOBILE
Scale SERP parses the Google scholar search results the scholar_results array in the JSON output when the search_type=scholar search parameter is set.

Below is an example of how the scholar_results array is represented in the Scale SERP result JSON:
{
"request_info": {
"success": true,
"credits_used": 1,
"credits_used_this_request": 1,
"credits_remaining": 19999,
"credits_reset_at": "2021-01-01T00:00:00.000Z"
},
"search_metadata": {
"created_at": "2021-01-01T00:00:00.000Z",
"processed_at": "2021-01-01T00:00:00.000Z",
"total_time_taken": 1.5,
"engine_url": "https://www.google.com/scholar?q=rubifen",
"html_url": "https://api.scaleserp.com/search?api_key=APIKEY&q=rubifen&location=United+States&search_type=scholar&engine=google&output=html",
"json_url": "https://api.scaleserp.com/search?api_key=APIKEY&q=rubifen&location=United+States&search_type=scholar&engine=google&output=json"
},
"search_parameters": {
"q": "rubifen",
"location": "United States",
"search_type": "scholar",
"engine": "google"
},
"search_information": {
"original_query_yields_zero_results": false,
"query_displayed": "rubifen"
},
"scholar_results": [
{
"position": 1,
"title": "[PDF][PDF] fárMaco de prueba",
"link": "http://www.pharmavita.cl/wp-content/uploads/2014/09/Brochure_RubifenPortada.pdf",
"domain": "www.pharmavita.cl",
"displayed_link": "I VIVo - pharmavita.cl",
"snippet": "… RuBIFEN® (Metilfenidato) puede ad- ministrarse tanto en presencia como en ausencia de\nalimentos junto con líquido … nota: puede ser conveniente suspender periódicamente el\ntratamiento con RuBI- FEN® (Metilfenidato) para evaluar el estado del niño",
"cited_by_count": 188,
"cited_by_link": "https://www.google.com/scholar?cites=2865832699770200924&as_sdt=2005&sciodt=0,5&hl=fr",
"pdf_link": "https://diabetesjournals.org/diabetes/article-pdf/62/10/3307/569495/3307.pdf",
"versions_count": 4,
"versions_link": "https://www.google.com/scholar?cluster=2865832699770200924&hl=fr&as_sdt=0,5"
},
{
"position": 2,
"title": "[HTML][HTML] MEDICINES ADVERSE REACTIONS COMMITTEE 20 March 2008 MEETING MINUTES",
"link": "https://medsafe.govt.nz/profs/adverse/Minutes133.htm",
"domain": "medsafe.govt.nz",
"displayed_link": "T Maling, H Kingston, F McClure, D Reith, L Bryant… - medsafe.govt.nz",
"snippet": "… 2.1.2 Rubifen SR (methylphenidate SR) brand switch - aggressive and defiant behavioural\nreactions December 2007 minute item 2.1.2, September 2007 minute item 3.2. Issue … Medsafe\nsought further information from the Rubifen product sponsor including the following",
"cited_by_count": 188,
"cited_by_link": "https://www.google.com/scholar?cites=2865832699770200924&as_sdt=2005&sciodt=0,5&hl=fr",
"versions_count": 4,
"versions_link": "https://www.google.com/scholar?cluster=2865832699770200924&hl=fr&as_sdt=0,5"
},
{
"position": 3,
"title": "Análisis de minimización de costes y del impacto sobre el presupuesto del Sistema Nacional de Salud del tratamiento del trastorno por déficit de atención con …",
"link": "https://link.springer.com/content/pdf/10.1007/BF03320877.pdf",
"domain": "link.springer.com",
"displayed_link": "C Rubio-Terrés, D Rubio-Rodríguez… - … Spanish Research Articles, 2012 - Springer",
"snippet": "… Resumen Introducción: No hay evidencia científica de diferencias significativas de efi- cacia\no tolerabilidad entre el metilfenidato de liberación inmediata (MLI; Rubifen®) y el de liberación\nprolongada (MLP; Medikinet®, Concerta®) en el tratamiento del trastorno por déficit de",
"cited_by_count": 188,
"cited_by_link": "https://www.google.com/scholar?cites=2865832699770200924&as_sdt=2005&sciodt=0,5&hl=fr",
"versions_count": 4,
"versions_link": "https://www.google.com/scholar?cluster=2865832699770200924&hl=fr&as_sdt=0,5"
},
{
"position": 4,
"title": "El impacto de la rehabilitación neuropsicológica en niños con TDAH",
"link": "http://dehesa.unex.es/handle/10662/6497",
"domain": "dehesa.unex.es",
"displayed_link": "AF Rodrigues - 2017 - dehesa.unex.es",
"snippet": "… La elección del tratamiento para el TDAH es la terapia de medicamentos, más específicamente\nmetilfenidato. Este componente se coloca en el mercado con los nombres comerciales de Ritalin\ny Rubifen … This component is marketed under the trade names Ritalin and Rubifen",
"cited_by_count": 188,
"cited_by_link": "https://www.google.com/scholar?cites=2865832699770200924&as_sdt=2005&sciodt=0,5&hl=fr",
"versions_count": 4,
"versions_link": "https://www.google.com/scholar?cluster=2865832699770200924&hl=fr&as_sdt=0,5"
},
{
"position": 5,
"title": "[PDF][PDF] Correlación electroclínica diagnóstica y terapéutica con metilfenidato de acción inmediata en TDAH",
"link": "https://www.seinap.es/wp-content/uploads/Revista-de-Pediatria/2004/REP%2060-3.pdf#page=7",
"domain": "www.seinap.es",
"displayed_link": "JRV Usón - ás se rna, 2004 - seinap.es",
"snippet": "… la respuesta clínica. Con estos parámetros, las dosis de MPH de liberación inmediata\n(Rubifen®) que se administraron fueron entre 10 a 40 mg, repartidas en el desayuno\ny la comida, según ne- cesidad clínica. Dentro de la"
},
{
"position": 6,
"title": "Metilfenidato: actualización de las condiciones de uso:(Nota informativa de la AEMPS 2009/01, de 22 de enero de 2009)",
"link": "https://dialnet.unirioja.es/servlet/articulo?codigo=2961760",
"domain": "dialnet.unirioja.es",
"displayed_link": "LG Juan - Actualidad en farmacología y terapéutica, 2009 - dialnet.unirioja.es",
"snippet": "… En nuestro país, el metilfenidato está comercializado como formulaciones de liberación inmediata\n(Rubifen®) y de liberación prolongada (Concerta® y Medikinet cápsulas®). Fundación Dialnet.\nAcceso de usuarios registrados. Identificarse ¿Olvidó su contraseña? ¿Es nuevo"
},
{
"position": 7,
"title": "[PDF][PDF] ESTADO ACTUAL DEL ENFOQUE DEL TDAH EN NEUROPEDIATRIA",
"link": "https://eventos.emagister.com/_files/_event/_7507/_editorFiles/file/pon/CARDO,%20ESTHER.pdf",
"domain": "eventos.emagister.com",
"displayed_link": "E Cardo, G Ros, J Eiris, C Escofet, A Fernández-Jaén… - eventos.emagister.com",
"snippet": "… respecto a la medicación utilizada, la mayoría de los pacientes se encontraban bajo tratamiento\ncon algún tipo de metilfenidato de liberación prolongada (Equasym©, Medikinet© o Concerta©),\nun porcentaje estable utilizaban Metilfenidato de liberación inmediata (Rubifen"
},
{
"position": 8,
"title": "Implicación del farmacéutico comunitario en la dispensación a pacientes con trastorno por déficit de atención e hiperactividad. Un estudio piloto",
"link": "http://pharmcareesp.com/index.php/PharmaCARE/article/view/88",
"domain": "pharmcareesp.com",
"displayed_link": "MD Palomino, MJ Martín-Calero… - Pharmaceutical Care …, 2012 - pharmcareesp.com",
"snippet": "… Metilfenidato de liberación inmediata Rubifen® 5, 10, 20 mg Comprimidos de liberación inmediata\n2-3 veces al día Dosis de inicio: 5 mg Incrementos semanales de 5 mg/toma (hasta ajustar la\ndosis) Dosis diaria ≤60 mg Efecto inmediato, duración de 2-4 h tras cada toma"
},
{
"position": 9,
"title": "Effect of switching drug formulations from immediate-release to extended-release OROS Methylphenidate",
"link": "https://link.springer.com/article/10.2165/00023210-200822070-00005",
"domain": "link.springer.com",
"displayed_link": "JA Ramos-Quiroga, R Bosch, X Castells, S Valero… - CNS drugs, 2008 - Springer",
"snippet": "… Abstract. Background: The potential advantages of osmotic-release oral system (OROS)\nmethylphenidate (Concerta®) over immediate-release (IR) methylphenidate (Rubifen®) in adults\nwith attention-deficit hyperactivity disorder (ADHD), with respect to medication adherence"
},
{
"position": 10,
"title": "The impact of psychopedagogical intervention on quality of life in adolescents with attention deficit hyperactivity disorder (ADHD) treated with psychostimulant …",
"link": "https://www.cambridge.org/core/journals/european-psychiatry/article/impact-of-psychopedagogical-intervention-on-quality-of-life-in-adolescents-with-attention-deficit-hyperactivity-disorder-adhd-treated-with-psychostimulant-medication/76422BADEBE6B6BD3687DE0B51358A81",
"domain": "www.cambridge.org",
"displayed_link": "C Lima, D Rodrigues, M Silva, S Rego - European Psychiatry, 2017 - cambridge.org",
"snippet": "… plans. The aim of this study was to evaluate the impact of a psychopedagogical\nintervention on quality of life of a sample of adolescents with ADHD taking into account\ntheir pharmacologi- cal plans (rubifen, ritalin, and concerta)"
}
],
"pagination": {
"current": 1,
"next": "https://www.google.com/scholar?start=10&q=rubifen&hl=en&as_sdt=0,48",
"other_pages": [
{
"page": 2,
"link": "https://www.google.com/scholar?start=10&q=rubifen&hl=en&as_sdt=0,48"
},
{
"page": 3,
"link": "https://www.google.com/scholar?start=20&q=rubifen&hl=en&as_sdt=0,48"
}
],
"api_pagination": {
"next": "https://api.scaleserp.com/search?api_key=APIKEY&q=rubifen&location=United%20States&search_type=scholar&engine=google&page=2",
"other_pages": [
{
"page": 2,
"link": "https://api.scaleserp.com/search?api_key=APIKEY&q=rubifen&location=United%20States&search_type=scholar&engine=google&page=2"
},
{
"page": 3,
"link": "https://api.scaleserp.com/search?api_key=APIKEY&q=rubifen&location=United%20States&search_type=scholar&engine=google&page=3"
}
]
}
},
"related_searches": [
{
"query": "text network analysis nursing",
"link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=1&q=text+network+analysis+nursing&qst=ib",
"type": "standard"
},
{
"query": "text network analysis gephi",
"link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=2&q=text+network+analysis+gephi&qst=ib",
"type": "standard"
},
{
"query": "text network analysis corpus studies",
"link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=3&q=text+network+analysis+corpus+studies&qst=ib",
"type": "standard"
},
{
"query": "text network analysis knowledge structure",
"link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=4&q=text+network+analysis+knowledge+structure&qst=ib",
"type": "standard"
},
{
"query": "text network analysis discourse bias",
"link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=5&q=text+network+analysis+discourse+bias&qst=ib",
"type": "standard"
},
{
"query": "text network analysis centrality",
"link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=6&q=text+network+analysis+centrality&qst=ib",
"type": "standard"
},
{
"query": "text network analysis public administration",
"link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=7&q=text+network+analysis+public+administration&qst=ib",
"type": "standard"
},
{
"query": "text network analysis kapucu",
"link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=8&q=text+network+analysis+kapucu&qst=ib",
"type": "standard"
}
]
}Scale SERP returns the following properties for search_type=scholar requests:
Property | Type | Description |
|---|---|---|
scholar_results | array | An array of Scholar Result objects, containing each of the scholar results returned. The Scholar Result object has the following properties:
|
pagination | object | An object containing details of the pagination section of the page. Details are provided as Google links and API links (to make sending paginated requests easier):
|
related_searches | array | An array of Related Search objects, containing each of the related searches shown at the bottom of the search results page. The Related Search object has the following properties:
|
Next Steps Google Scholar Parameters